1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Russia >
  5. Abbott Acquires Veropharm

M&A Deal Summary

Abbott Acquires Veropharm

On June 23, 2014, Abbott acquired life science company Veropharm for 305M USD

Acquisition Highlights
  • This is Abbott’s 11th transaction in the Life Science sector.
  • This is Abbott’s 22nd largest (disclosed) transaction.
  • This is Abbott’s 1st transaction in Russia.

M&A Deal Summary
Date 2014-06-23
Target Veropharm
Sector Life Science
Buyer(s) Abbott
Deal Type Add-on Acquisition
Deal Value 305M USD

Target

Veropharm

Moscow, Russia
Veropharm is a Russian pharmaceutical producer known in Russia and abroad as one of Russia’s major manufacturers of generic drugs that are identical to their brand name counterparts, oncological medications, and medical adhesive bandages.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abbott

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 26 of 36
Sector: Life Science M&A 11 of 12
Type: Add-on Acquisition M&A Deals 26 of 36
Country: Russia M&A 1 of 1
Year: 2014 M&A 2 of 3
Size (of disclosed) 22 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-16 CFR Pharmaceuticals S.A.

Providencia,, Chile

CFR Pharmaceuticals S.A. is engaged in the research, development, production, and sale of specialty generic medicines and complex injectables.

Buy $2.9B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-29 Topera

San Diego, California, United States

Topera, Inc. has developed a novel diagnostic catheter and mapping software, or rotor identification system, which help physicians identify and target the specific areas of a person’s heart that are perpetuating atrial fibrillation.

Buy $250M
Mergr

Solution for

Product

Company

Legal